UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Autoimmune Acute Liver Failure: Proposed Clinical and Histological Criteria

Hepatology (Baltimore, Md.), 2011-02, Vol.53 (2), p.517-526

2011

Volltextzugriff (PDF)

Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2‐Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti–Domain 1 to Anti–Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2015-05, Vol.67 (8), p.2196-2204

2015

Volltextzugriff (PDF)

The interplay of type I and type II interferons in murine autoimmune cholangitis as a basis for sex‐biased autoimmunity

Hepatology (Baltimore, Md.), 2018-04, Vol.67 (4), p.1408-1419

2018

Volltextzugriff (PDF)

Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis

Liver international, 2012-01, Vol.32 (1), p.85-92

2012

Volltextzugriff (PDF)

Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis

Liver international, 2015-02, Vol.35 (2), p.642-651

2015

Volltextzugriff (PDF)

Association between serum soluble CD14 and IL‐8 levels and clinical outcome in primary biliary cholangitis

Liver international, 2017-06, Vol.37 (6), p.897-905

2017

Volltextzugriff (PDF)

The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17a deleted dominant negative form of transforming growth factor beta receptor type ii mice

Hepatology (Baltimore, Md.), 2012-10, Vol.56 (4), p.1418-1426

2012

Volltextzugriff (PDF)

Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis

Alimentary pharmacology & therapeutics, 2021-01, Vol.53 (2), p.302-313

2021

Volltextzugriff (PDF)

Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID‐19 severity: An Italian study

Journal of medical virology, 2022-12, Vol.94 (12), p.5758-5765

2022

Volltextzugriff (PDF)

Autoimmune acute liver failure: Proposed clinical and histological criteria

Hepatology (Baltimore, Md.), 2011-02, Vol.53 (2), p.517-526

2011

Volltextzugriff (PDF)

Comparison of celiac disease markers in women with early recurrent pregnancy loss and normal controls

American journal of reproductive immunology (1989), 2019-07, Vol.82 (1), p.e13127-n/a

2019

Volltextzugriff (PDF)

Calprotectin Impairs Platelet Survival in Patients With Primary Antiphospholipid Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2024-06, Vol.76 (6), p.928-935

2024

Volltextzugriff (PDF)

Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis

Hepatology (Baltimore, Md.), 2007-11, Vol.46 (5), p.1436-1442

2007

Volltextzugriff (PDF)

Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis

Hepatology (Baltimore, Md.), 2007-11, Vol.46 (5), p.1436-1442

2007

Volltextzugriff (PDF)

Clinical performance of automated chemiluminescent methods for anticardiolipin and anti‐β2‐glycoprotein I antibodies detection in a large cohort of Chinese patients with antiphospholipid syndrome

International journal of laboratory hematology, 2020-04, Vol.42 (2), p.206-213

2020

Volltextzugriff (PDF)

Association between serum soluble CD 14 and IL ‐8 levels and clinical outcome in primary biliary cholangitis

Liver international, 2017-06, Vol.37 (6), p.897-905

2017

Volltextzugriff (PDF)

Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against [beta]2-Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti-Domain 1 to Anti-Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2015-08, Vol.67 (8), p.2196

2015

Volltextzugriff (PDF)

Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β 2 ‐Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti–Domain 1 to Anti–Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2015-05, Vol.67 (8), p.2196-2204

2015

Volltextzugriff (PDF)

Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against beta sub(2)-Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti-Domain 1 to Anti-Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2015-05, Vol.67 (8), p.2196-2204

2015

Volltextzugriff (PDF)

The Immunobiology of Colitis and Cholangitis in IL-23p19 and IL-17A Deleted dnTGFβRII Mice

Hepatology (Baltimore, Md.), 2012-10, Vol.56 (4), p.1418-1426

2012

Volltextzugriff (PDF)

Value of Isolated IgA anti-β2GPI Positivity in the Diagnosis of the Antiphospholipid Syndrome

Arthritis and rheumatism, 2013-12, Vol.65 (12), p.3186-3193

2013

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(63)
Reviews
(2)

Sprache

Englisch
(65)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(37)
Humans
(30)
Female
(21)
Male
(19)
Adult
(17)
Middle Aged
(15)
Biological And Medical Sciences
(13)
Gastroenterology & Hepatology
(12)
Aged
(11)
Medical Sciences
(11)
Animals
(9)
Follow-Up Studies
(7)
Adolescent
(6)
Dentistry
(6)
Gastroenterology. Liver. Pancreas. Abdomen
(6)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(6)
Autoantibodies - Blood
(5)
Hepatology
(5)
Liver
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Autoimmune Acute Liver Failure: Proposed Clinical and Histological Criteria

Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2‐Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti–Domain 1 to Anti–Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

The interplay of type I and type II interferons in murine autoimmune cholangitis as a basis for sex‐biased autoimmunity

Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis

Anti‐gp210 and anti‐centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis

Association between serum soluble CD14 and IL‐8 levels and clinical outcome in primary biliary cholangitis

The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17a deleted dominant negative form of transforming growth factor beta receptor type ii mice

Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis

Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID‐19 severity: An Italian study

Autoimmune acute liver failure: Proposed clinical and histological criteria

Comparison of celiac disease markers in women with early recurrent pregnancy loss and normal controls

Calprotectin Impairs Platelet Survival in Patients With Primary Antiphospholipid Syndrome

Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis

Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis

Clinical performance of automated chemiluminescent methods for anticardiolipin and anti‐β2‐glycoprotein I antibodies detection in a large cohort of Chinese patients with antiphospholipid syndrome

Value of Isolated IgA Anti–β2‐Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome

Association between serum soluble CD 14 and IL ‐8 levels and clinical outcome in primary biliary cholangitis

Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against [beta]2-Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti-Domain 1 to Anti-Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β 2 ‐Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti–Domain 1 to Anti–Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against beta sub(2)-Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti-Domain 1 to Anti-Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

The Immunobiology of Colitis and Cholangitis in IL-23p19 and IL-17A Deleted dnTGFβRII Mice

Value of Isolated IgA Anti–β 2 ‐Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome

Value of Isolated IgA Anti-[beta]2-Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome

Value of Isolated IgA anti-β2GPI Positivity in the Diagnosis of the Antiphospholipid Syndrome

Aktive Filter

Suchergebnisse filtern